Bid Cap
Company library Industrials & Energy

Company report

Oklo Inc. OKLO

Three-pass checked

The bet you're really making is that Oklo builds small nuclear power plants, owns them, and sells the electricity to data centers and the military under long-term contracts, instead of selling the reactors themselves. You're betting the government's nuclear regulator approves the first plant at the Idaho lab and that it gets built close to the promised time and cost. Right now nothing is running: Oklo sold no power last quarter, booked $1.2 million from three small engineering firms it just bought, and lost $48.5 million. You pay $7.2 billion for that promise, and even after the company raised over $1.5 billion in cash you are paying 2.2 times what it is worth on paper, for a company that has never sold a kilowatt of its own power.

Key data

Price$41.27
52-week range$36.61 to $193.84
Price / book2.2x
Enterprise value$5.54B

OKLO · price with moving averages

Daily · 6MWeekly · 3Y
$-7$39$84$130$176 May '24Oct '24Apr '25Oct '25Apr '26Oct '26 Bid Cap
EMAs82140

Source: market data.

The business

Oklo designs the Aurora, a small fast-fission "powerhouse" that starts around 15 megawatts and scales up, cooled by liquid metal and descended from an old Idaho test reactor. The twist that defines the company is the sales model: it does not sell reactors, it plans to build and own them and sell the electricity under multi-year power contracts, the way an independent power producer does. Its customers so far are letters of intent and framework agreements, weighted toward data-center operators desperate for round-the-clock power and a military base in Alaska. In June 2026 Oklo bought three engineering and fuel-services firms, ARMEC, Precision Manufacturing Engineering Solutions, and Creative Engineers, which is where the first $1.2 million of revenue comes from. The moat, if it earns one, is a granted regulatory license plus secured fuel and a site, none of which it holds in commercial form yet. Everything rests on a first plant that does not exist.

The numbers

There is no earnings story here, only a burn story and a funding story, and both are the whole point. The last five quarters:

QuarterRevenueNet lossDiluted EPS
Q2 2025$0$24.7M-$0.18
Q3 2025$0$29.7M-$0.20
Q4 2025$0$41.4M-$0.27
Q1 2026$0$33.1M-$0.19
Q2 2026$1.2M$48.5M-$0.28

The loss roughly doubled in a year as Oklo hired, engineered, and absorbed acquisitions. The full-year picture shows the same slope, steeper each year:

Fiscal yearNet lossDiluted EPS
2023$32.2M-$0.47
2024$73.6M-$0.74
2025$105.7M-$0.72
2026, 1H to Jun$81.6M-$0.47

Notice the loss per share barely widened even as the loss doubled, because the share count ballooned. That dilution is the second story, and it funded the first. Here is the cash against the burn:

QuarterCash, $BNet loss, $M
2025-060.2324.7
2025-090.4129.7
2025-120.7941.4
2026-031.5933.1
2026-061.6448.5

Cash went from $90 million at the end of Q1 2025 to $1.64 billion at the end of Q2 2026, a fifteen-month rise funded by selling stock into a rising market, and that is why the company is funded for years of operating losses. The catch hides in what the cash has not yet done: capital spending was $33 million for all of 2025, a rounding error against what a fleet of reactors costs. The money is raised, the construction has barely begun, and the gap between those two facts is the timeline to first power. What this memo believes that the price does not is plain: the burn and the build are still ahead, not behind, and the single print that settles the story is not an earnings number at all but the regulator's decision on the first plant.

Management

Co-founder and chief executive Jacob DeWitte and finance chief Craig Bealmear were sellers, not buyers: about $60 million sold across 49 filings in twelve months, zero purchases, DeWitte's stock leaving in steady monthly slices that look automatic but whose plan status is not disclosed in the filings I can see. There is no profit to judge pay against, so compensation runs on stock, which feeds the same dilution the share count already shows. The team's proven record is capital-raising, and at that they have been effective, turning a hot story and a rising stock into a war chest. That is a real skill for a company at this stage. It is not the same skill as building reactors on budget, which remains untested.

How it fails or surprises you

The license does not come, or comes late. The regulator turned Oklo's first application away in 2022 for thin detail, and the company has not yet cleared a resubmission. If approval slips past 2028 or arrives narrowed, the whole revenue timeline moves right and the cash burns against nothing. Watch the licensing docket for the first Aurora.

Dilution never stops. The $1.6 billion does not build a fleet; the first commercial plants cost billions more, and with no earnings that money comes from selling more stock, likely below the old highs. Watch shares outstanding each quarter against capital spending. Rising shares with flat capex is the bad combination.

Data-center demand converts (right tail). Hyperscalers are signing for firm power years out and paying up for it. If even a slice of Oklo's gigawatt-scale interest list becomes binding contracts and the first plant runs, a build-own-operate fleet throws off decades of contracted cash the market prices at almost nothing today. Watch for the first binding power contract with a construction start date attached.

Closing thoughts

Nothing in the next four quarters settles this. It is a survival-and-permission story: whether the cash lasts to a licensed, operating first plant, with everything else noise until then. The near-term tail is fatter on the downside, delay and dilution, because those are the default paths for a pre-revenue builder, and the market has already marked the stock down almost 80% from its high to say so. The right tail is genuinely large and genuinely unpriced, but it pays out on no schedule you can underwrite. What is at risk if licensing breaks is most of the equity; what the upside is worth is a power producer with a multi-decade contracted book, and only one of those is knowable in advance.

The bet is still that Oklo builds small nuclear power plants, owns them, and sells the electricity to data centers and the military. It breaks if the regulator says no or if the cost of building forces endless share issuance, and it wins if the first plant clears its license and runs. The one pair that tells you which way it is going, quarter by quarter, is the licensing milestone on the first Aurora set against capital spending rising into that cash balance. Everything else on this page is a way of waiting for those two numbers.

Methodology

Sources: Oklo's 10-Q filed Aug 7, 2026 (period ended Jun 30, 2026) and prior annual filings for the as-filed figures; market, valuation, and consensus data current to Sep 7, 2026.

Q4 2025 net loss ($41.4M) and diluted EPS (-$0.27) are derived as full-year 2025 less the nine months filed through Sep 30, 2025, because the vendor feed skips that quarter.

Pre-June-2026 quarterly revenue shown as $0 reflects no product revenue before the June 2026 services acquisitions; the $1.2M in Q2 2026 is filed.

Valuation uses price-to-book and enterprise value rather than P/E, which is meaningless for a loss-making, pre-revenue company; figures from vendor ratios tied to the filed balance sheet.

Insider figures are trailing-twelve-month Form 4 sales; 10b5-1 plan status is not stated in the feed, so no sale is called planned.

Fact check: all numerical financials reconciled to filed XBRL (revenue, losses, EPS, cash, capex, insider sales). Corrected cash timeline from "in a year" to "fifteen months" (Q1 2025 to Q2 2026). Executive names and qualitative business claims not independently web-verified (sources unreachable in execution environment). Verified Sep 7, 2026.

Bid Cap

Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.

Subscribe on Substack